ARROWHEAD PHARMACEUTICALS, INC. Quarterly Operating Lease, Payments in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q4 2019 to Q3 2024.
  • Arrowhead Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $3.71M, a 317% increase year-over-year.
  • Arrowhead Pharmaceuticals, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $11M, a 112% increase year-over-year.
  • Arrowhead Pharmaceuticals, Inc. annual Operating Lease, Payments for 2024 was $11M, a 112% increase from 2023.
  • Arrowhead Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $5.2M, a 15.6% increase from 2022.
  • Arrowhead Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $4.5M, a 45.2% increase from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $11M $3.71M +$2.82M +317% Jul 1, 2024 Sep 30, 2024 10-K 2024-11-26
Q2 2024 $8.22M $3.2M +$1.32M +70% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $6.9M $2.05M +$948K +86.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $5.95M $2.08M +$749K +56.3% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-06
Q3 2023 $5.2M $890K Jul 1, 2023 Sep 30, 2023 10-K 2024-11-26
Q2 2023 $1.89M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.1M -$1.07M -49.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.33M +$331K +33.1% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-06
Q1 2022 $2.17M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $1M +$300K +42.9% Oct 1, 2021 Dec 31, 2021 10-Q 2022-02-02
Q4 2020 $2.2M $700K +$400K +133% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-02
Q3 2020 $1.8M $700K Jul 1, 2020 Sep 30, 2020 10-K 2021-11-22
Q2 2020 $500K Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $300K Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $300K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.